Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
BlaOXA
83%
KPC-2
68%
National Reference Laboratory
67%
Cystic Fibrosis
66%
Pulsed-field Gel Electrophoresis
55%
Plasmid
53%
Klebsiella Pneumoniae (K. pneumoniae)
51%
Enterobacteriaceae
51%
Sequence Type
48%
Whole Genome Sequencing
44%
BlaOXA-48-like
39%
Carbapenemase
38%
Carbapenemase-producing Enterobacterales
33%
Neisseria Gonorrhoeae
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Carbapenemases
33%
OXA-48
33%
West Midlands
33%
Variable number Tandem Repeat
33%
United Kingdom
33%
Azithromycin
33%
Achromobacter Xylosoxidans
33%
Burkholderia multivorans
33%
Molecular Comparison
33%
Carbapenemase Genes
33%
Carbapenemase-producing Enterobacteriaceae
33%
Azithromycin Resistance
33%
Antiretroviral
33%
Amprenavir
33%
KPC-3
33%
Klebsiella Pneumoniae Carbapenemase
33%
Ceftazidime Resistance
33%
Northwest Region
33%
Avibactam
33%
In Vitro Selection
33%
HIV-infected Adults
33%
Antiretroviral Activity
33%
Abacavir
33%
Dose-ranging Study
33%
Ceftazidime-avibactam
26%
BlaNDM-1
26%
Patient Data
24%
Amplicon
22%
FliC
22%
N. Gonorrhoeae
22%
Plasmid Analysis
22%
Core Genome multilocus Sequence Typing (cgMLST)
20%
Carbapenem
18%
Agar Dilution
17%
Twice Daily
17%
Immunology and Microbiology
Plasmid
100%
Minimum Inhibitory Concentration
96%
Klebsiella pneumoniae
61%
Enterobacteriaceae
52%
Whole Genome Sequencing
44%
Multilocus Sequence Typing
34%
Replicon
34%
Amplicon
33%
in Vitro Selection
33%
Achromobacter Xylosoxidans
33%
Burkholderia multivorans
33%
Carbapenemase Producing Enterobacteriaceae
33%
Pseudomonas aeruginosa
33%
Enterobacterales
33%
Neisseria gonorrhoeae
33%
Restriction Fragment Length Polymorphism
33%
Allele
27%
Enterobacter Cloacae
23%
Amino Acid
22%
Agar Dilution
18%
Patient Coding
18%
Genome Sequencing
17%
Variable Number of Tandem Repeat
16%
Tandem Repeat
16%
Next Generation Sequencing
16%
Flagellin
16%
Genetic Variation
16%
Illumina Dye Sequencing
16%
Restriction Enzyme
16%
Infectious Disease
16%
Infection
16%
Emerging Pathogen
16%
Epidemiology
13%
Cohort Effect
13%
Escherichia coli
12%
RNA Gene
11%
Carboxy Terminal Sequence
11%
Susceptibility
8%
Ethylenediaminetetraacetic Acid
5%
Wild Type
5%
Single Nucleotide Polymorphism
5%
Antigen
5%
Bacterium
5%
Ribosomal RNA
5%
Ribosome RNA
5%
